World Investment Advisors Invests $888,000 in DENTSPLY SIRONA Inc. $XRAY

World Investment Advisors bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 3rd quarter, HoldingsChannel reports. The institutional investor bought 69,949 shares of the medical instruments supplier’s stock, valued at approximately $888,000.

Other large investors have also recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of DENTSPLY SIRONA during the first quarter worth $26,000. Trust Co. of Toledo NA OH bought a new stake in shares of DENTSPLY SIRONA in the 2nd quarter valued at about $27,000. Parkside Financial Bank & Trust increased its stake in shares of DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after buying an additional 1,477 shares during the period. True Wealth Design LLC raised its position in shares of DENTSPLY SIRONA by 273.0% during the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after acquiring an additional 1,739 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB boosted its holdings in DENTSPLY SIRONA by 160.2% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 2,805 shares of the medical instruments supplier’s stock valued at $45,000 after acquiring an additional 1,727 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on XRAY. Barrington Research restated an “outperform” rating and issued a $14.00 price target on shares of DENTSPLY SIRONA in a research report on Tuesday, December 16th. Wall Street Zen downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Saturday, October 18th. Evercore ISI dropped their target price on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating on the stock in a report on Wednesday, October 8th. Zacks Research downgraded DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a report on Monday, November 10th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus target price of $15.15.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Price Performance

XRAY stock opened at $11.52 on Monday. The company has a debt-to-equity ratio of 1.36, a current ratio of 1.47 and a quick ratio of 0.99. The company’s 50-day moving average is $11.54 and its 200-day moving average is $13.40. The stock has a market capitalization of $2.30 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 0.84 and a beta of 1.01. DENTSPLY SIRONA Inc. has a 1 year low of $9.85 and a 1 year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 17.10% and a negative net margin of 24.34%.The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same period last year, the company posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 9th. Investors of record on Friday, December 26th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 5.6%. The ex-dividend date is Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.48%.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.